Loading grant details…
PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials
| Funder | European Commission |
|---|---|
| Recipient Organization | Oslo Universitetssykehus Hf |
| Country | Norway |
| Start Date | Jul 01, 2023 |
| End Date | Jun 30, 2028 |
| Duration | 1,826 days |
| Number of Grantees | 24 |
| Roles | Associated Partner; Participant; Coordinator |
| Data Source | European Commission |
| Grant ID | 101104269 |
Grant Description
Millions of people in the EU are negatively affected by cancer, and cancer is one of the leading causes of death and morbidity in Europe (ecis.jrc.europa.eu).
The PRIME-ROSE consortium will contribute to the Mission Cancer goal to optimise treatment and support quality of life of more than 3 million people by 2030.The PRIME-ROSE consortium envisions to support Mission Cancer through the following objectives: 1) increase access to optimised and affordable treatment interventions for cancer patients that prolong life and increase quality of life, 2) generate clinical evidence and evaluate effectiveness in Precision Cancer Medicine (PCM)-relevant and synthetically randomised, controlled academic investigator-initiated pragmatic clinical trials, and 3) work together across Europe with relevant experts to implement evidence-based PCM in routine practice and address inequalities in access.This consortium builds on the truly bottom-up, clinician-initiated family of DRUP-like innovative trials that provide broad access to precision medicine for cancer patients.This action is part of the Cancer Mission cluster of projects on ‘Diagnosis and treatment’.
All Grantees
Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie -Panstwowy Instytut Badawczy; Academisch Ziekenhuis Leiden; Region Hovedstaden; Asociatia Centrul Pentru Inovatie in Medicina; Fundacio Privada Institut D'Investigacio Oncologica de Vall-Hebron (Vhio); Cancer Research Uk Lbg; Hus-Yhtyma; The University of Manchester; The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near Dublin; Nacionalinis Vezio Institutas; Klinicki Bolnicki Centar Split; Centre de Lutte Contre Le Cancer Leon Berard; Sihtasutus Tartu Ulikooli Kliinikum; Oslo Universitetssykehus Hf; Ihe, Institutet for Halso- Och Sjukvardsekonomi Aktiebolag; Stichting Radboud Universitair Medisch Centrum; Masarykuv Onkologicky Ustav; Universitatsklinikum Heidelberg; Karolinska Institutet; Instituto Portugues de Oncologia Do Porto Francisco Gentil, Epe; Region Uppsala; Stiftelsen Stockholm School of Economics (Sse) Institute for Research; Orszagos Onkologiai Intezet; Region Skane
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Related Grants
